Cancer Drugs Fund: Kadcyla back on list

Google+ Pinterest LinkedIn Tumblr +

kadclyaBy Smitha Mundasad – BBC.

The Cancer Drugs Fund will continue to pay for the breast cancer treatment Kadcyla, after the company Roche cut its price, the NHS in England has said.

The fund, which pays for drugs not routinely available on the NHS, has been cutting the number it offers, in order to balance the books.

Many, including breast cancer treatment Avastin, remain off the fund’s list, as treatments for certain tumours.

Charities say the fund is worryingly unstable and causes patients anxiety…read the full article.

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.